Durable left ventricular assist devices (dLVAD) remain a lifesaving therapy in patients with stage D heart failure that is refractory to conventional medical therapies. Owing to improvements in technology and patient outcomes, the number of patients supported with dLVADs has increased over the past decade. Despite this growing population, there are few resources for cardiovascular intensivists that integrate epidemiology, diagnostic workup and multidisciplinary medical management of acute emergencies in patients supported with dLVADs.
EditorsEditor-in-ChiefHarlan M. Krumholz, MD, SM, FACC CME EditorRagavendra R. Baliga, MD
AuthorAniket S. Rali, MD
Important DatesDate of Release: July 7, 2026Term of Approval/Date of CME/MOC Expiration: July 6, 2027